Skip to main content

Table 4 Areas under the ROC curve for WHO classification and PD-NLR for predicting OS and DFS in patients with surgically resected neuroendocrine tumors in the head of the pancreas

From: Clinical significance of the preoperative main pancreatic duct dilation and neutrophil-to-lymphocyte ratio in pancreatic neuroendocrine tumors (PNETs) of the head after curative resection

Variable

OS

DFS

Area under the ROC curve (95% CI)

P

Area under the ROC curve (95% CI)

P

PD-NLR

0.886 (0.788–0.985)

< 0.001

0.889 (0.795–0.983)

< 0.001

PD

0.785 (0.641–0.929)

0.001

0.757 (0.618–0.896)

0.001

NLR (≤ 3.1/ > 3.1)

0.772 (0.619–0.925)

0.002

0.791 (0.655–0.927)

< 0.001

WHO classification

0.818 (0.699–0.938)

< 0.001

0.858 (0.761–0.955)

< 0.001

  1. ROC Receiver operating characteristic, OS Overall survival, DFS Disease-free survival, PD Main pancreatic duct dilation, NLR Neutrophil-to-lymphocyte ratio. P-values < 0.05, marked in bold font, indicate statistical significance
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us